The bigger picture
Median is working at the epicentre of the advances taking place in medicine. Their specialised imaging biomarker expertise allows them to be detailed, accurate and consistent in the analysis of what that image reveals.
Working with pharmaceutical and biotechnology companies, leading medical centres and academia, they are building a substantial capacity to gather more and more information from medical images, finding the fingerprint of diseases in an images, paving the way for the discovery of new personalised and innovative medicines and for better patient diagnosis and treatment. Image biomarker analysis using Big Data analytics has an important part to play in this vision of the future in many areas of medicine.
The sheer volume of information they are able to access through images is impressive in its own right. What’s more impressive is what they can do with it. The timing could not be better, coinciding as it does with the progress being made in the rapidly advancing world of personalised and precision medicine, where detailed, accurate, quantitative imaging is so important. It’s here that they can open up new and exciting possibilities in clinical trials and patient care.
thinkerdoer’s role was to articulate this story, clarify the key messages and reinvent the brand to maximise visibility as the company embarks on its impressive growth ambitions with particular focus on European and United States operations.